BioCryst Pharmaceuticals | 보통주 자본

Ordinary Share Capital 변화 날짜
Alnylam Pharmaceuticals USD 1.26M 4K 2023-12
Gilead Sciences USD 1000K 0 2023-09
Intra Cellular Therapies USD 10K 0 2023-12
Ionis Pharmaceuticals USD 144K 1000 2023-12
Regeneron Pharmaceuticals USD 102K 0 2023-09
Roche Holding CHF 107M 0 2023-06
Ultragenyx Pharmaceutical USD 72K 1000 2023-09
Vertex Pharmaceuticals USD 2.6M 0 2023-09



BioCryst Pharmaceuticals 보통주 자본 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - May 2024.